Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient

American Journal of Kidney Diseases

Volumn 41, Issue 6, 2003, Pages 1257-1266

  Lee, Seoung Woo ^b   Song, Joon Ho ^b   Kim, Gyeong A ^b   Lim, Hee Jung ^b   Kim, Moon Jae ^a  

^a Inha University Hospital   (South Korea)

^b NONE

Author keywords

Atrial natriuretic peptide (ANP); Brain natriuretic peptide (BNP); Dry weight (DW); Hemodialysis (HD); Hydration status

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CIRCULATION; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; EVALUATION; EXTRACELLULAR FLUID; FEMALE; HEART DILATATION; HEART DISEASE; HEART STRESS; HEART VENTRICLE SIZE; HEMODIALYSIS; HUMAN; HYDRATION; IMPEDANCE; INFERIOR CAVA VEIN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN BLOOD LEVEL; PULSE PRESSURE; ROC CURVE; STATISTICAL SIGNIFICANCE; TOTAL BODY WATER;

EID: 0038439449     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00358-5     Document Type: Article

References (44)

1. Foley RN, Parfrey PS, Harnett JD, et al: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47:186-192, 1995
2. Parfrey PS, Harnett JD: Clinical aspects of cardiomyopathy in dialysis patients. Blood Purif 12:267-276, 1994
3. Venkatesan J, Henrich WL: Anemia, hypertension, and myocardial dysfunction in end-stage renal disease. Am J Kidney Dis 17:257-269, 1997
4. Zoccali C, Ciccarelli M, Mallamaci F, et al: Effect of ultra-filtration on plasma concentrations of atrial natriuretic peptide in hemodialysis patients. Nephrol Dial Transplant 1:188-191, 1986
5. Leunissen KM, Menheere PP, Cheriex EC, van den Berg BW, Noordzij TC, van Hooff JP: Plasma alpha-human atrial natriuretic peptide and volume status in chronic hemodialysis patients. Nephrol Dial Transplant 4:382-386, 1989
6. Fishbane S, Natke E, Maesaka JK: Role of volume overload in dialysis-refractory hypertension. Am J Kidney Dis 28:257-261, 1996
7. Kohse KP, Feifel K, Mayer-Wehrstein R: Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Clin Nephrol 40:83-90, 1993
8. Stein BC, Levin RI: Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 135:914-923, 1998
9. Mukoyama M, Nakao K, Hosoda K, et al: Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 87:1402-1412, 1991
10. Yasue H, Yoshimura M, Sumida H, et al: Localization and mechanism of secretion of B-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90:195-203, 1994
11. Clerico A, Iervasi G, Del Chicca MG, et al: Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 21:170-179, 1998
12. Nishikimi T, Yoshihara F, Morimoto A, et al: Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28:22-30, 1996
13. Nishikimi T, Futoo Y, Tamano K, et al: Plasma brain natriuretic peptide levels in chronic hemodialysis patients: Influence of coronary artery disease. Am J Kidney Dis 37:1201-1208, 2001
14. Osajima A, Okazaki M, Kato H, et al: Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease. Am J Nephrol 21:112-119, 2001
15. Edhouse J, Thakur RK, Khalil JM: ABC of clinical electrocardiography: Conditions affecting the left side of the heart. BMJ 324:1264-1267, 2002
16. Cheriex EC, Leunissen KML, Janssen JHA, Mooy JMV, van Hooff JP: Echography of the inferior vena cava is a simple and reliable tool for estimation of 'dry weight' in haemodialysis patients. Nephrol Dial Transplant 4:563-568, 1989
17. Mosteller RD: Simplified calculation of body surface area. N Engl J Med 317:1098, 1987 (letter)
18. Bedogni G, Malavolti M, Severi S, et al: Accuracy of an 8-point tactile-electrode impedance method in the assessment of total body water. Eur J Clin Nutr 56:1143-1148, 2002
19. Cha K, Chertow GM, Gonzalez J, Lazarus JM, Wilmore DW: Multifrequency bioelectrical impedance estimates the distribution of body water. J Appl Physiol 79:1316-1319, 1995
20. Oe B, De Fijter WH, Oe PL, Stevens P, De Vries PMJM: Diameter of inferior caval vein (VCD) and bioelectrical impedance analysis (BIA) for the analysis of hydration status in patients on hemodialysis. Clin Nephrol 50:38-43, 1998
21. Oe B, De Fijter WM, De Fijter CWH, et al: Detection of hydration status by total body bioelectrical impedance analysis (BIA) in patients on hemodialysis. Int J Artif Organs 20:371-374, 1997
22. Jaeger JQ, Mehta RL: Dry weight and body composition in hemodialysis: A proposal for an index of fluid removal. Semin Dial 12:164-174, 1999
23. US Renal Data System: USRDS 1997 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1997
24. Raine AEG, Margretter R, Brunner FP, et al: Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 7:S7-S35, 1992 (suppl 2)
25. Henrich WL: Approach to volume control, cardiac preservation, and blood pressure control in the pre-end-stage renal disease patient. J Am Soc Nephrol 9:S63-S65, 1998 (suppl 12)
26. Mallamaci F, Zoccali C, Tripepi G, et al: Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 59:1559-1566, 2001
27. Zoccali C, Mallamaci F, Benedetto FA, et al: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12:1508-1515, 2001
28. Leunissen KML, Kouw P, Kooman JP, et al: New techniques to determine fluid status in hemodialyzed patients. Kidney Int Suppl 41:S50-S56, 1993
29. Mandelbaum A, Ritz E: Vena cava diameter measurement for estimation of dry weight in haemodialysis patients. Nephrol Dial Transplant 11:24-27, 1996 (suppl 2)
30. Spiegel DM, Bashir K, Fisch B: Bioimpedance resistance ratios for the evaluation of dry weight in hemodialysis. Clin Nephrol 53:108-114, 2000
31. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 339:321-328, 1998
32. Ogawa Y, Nakano K, Mukoyama M, et al: Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats: The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res 69:491-500, 1991
33. Suzuki E, Hirata Y, Kohmoto O, et al: Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells. Circ Res 71:1039-1048, 1992
34. Mantymaa P, Vuolteenaho O, Marttila M, Ruskoaho H: Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro. Endocrinology 133:1470-1473, 1993
35. Lang CC, Choy AM, Turner K, Tobin R, Coutie W, Struthers AD: The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in man. J Hypertens 11:737-741, 1993
36. Yoshimura T, Yoshimura M, Yasue H, et al: Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal human pregnancy and the postpartum period. J Endocrinol 140:393-397, 1994
37. Nitta K, Kawashima A, Yumura W, et al: Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am J Nephrol 18:411-415, 1998
38. Sugihara K, Fujimoto S, Motomiya Y, Hashimoto T, Nakamura S, Dohi K: Usefulness of long axis M-mode echocardiographic measurements for optimum dialysis in patients on maintenance hemodialysis: Comparison with changes in plasma levels of atrial natriuretic peptide and brain natriuretic peptide. Clin Nephrol 56:140-149, 2001
39. Safar ME: Pulse pressure in essential hypertension: Clinical and therapeutical implications. J Hypertens 7:769-776, 1989
40. London GM, Guerin AP, Marchais SJ, et al: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50:600-608, 1996
41. Tozawa M, Iseki K, Iseki C, Takishita S: Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 61:717-726, 2002
42. Katzarski KS, Nisell J, Randmaa I, Danielsson A, Freyschuss U, Bergstrom J: A critical evaluation of ultrasound measurement of inferior vena cava diameter in assessing dry weight in normotensive and hypertensive hemodialysis patients. Am J Kidney Dis 30:459-465, 1997
43. Katzarski K, Charra B, Laurent G, et al: Multifrequency bioimpedance in assessment of dry weight in haemodialysis. Nephrol Dial Transplant 11:S20-S23, 1996 (suppl 2)
44. Pupim LB, Kent P, Ikizler TA: Bioelectrical impedance analysis in dialysis patients. Miner Electrolyte Metab 25:400-406, 1999